ISSN 1008-2204
CN 11-3979/C

中国医药制造业研发效率及其收敛趋势——基于DEA-Malmquist指数的实证分析

邹文杰

邹文杰. 中国医药制造业研发效率及其收敛趋势——基于DEA-Malmquist指数的实证分析[J]. 北京航空航天大学学报社会科学版, 2013, 26(6): 69-73.
引用本文: 邹文杰. 中国医药制造业研发效率及其收敛趋势——基于DEA-Malmquist指数的实证分析[J]. 北京航空航天大学学报社会科学版, 2013, 26(6): 69-73.
Zou Wenjie. China’s Pharmaceutical Manufacturing R&D Efficiency and Its Convergence:Based on the DEA-Malmquist Index Approach[J]. Journal of Beijing University of Aeronautics and Astronautics Social Sciences Edition, 2013, 26(6): 69-73.
Citation: Zou Wenjie. China’s Pharmaceutical Manufacturing R&D Efficiency and Its Convergence:Based on the DEA-Malmquist Index Approach[J]. Journal of Beijing University of Aeronautics and Astronautics Social Sciences Edition, 2013, 26(6): 69-73.

中国医药制造业研发效率及其收敛趋势——基于DEA-Malmquist指数的实证分析

基金项目: 教育部人文社会科学研究规划青年基金资助项目(12YJC790301);福建师范大学青年科研骨干教师基金资助项目(fjsdjk2012008)
详细信息
    作者简介:

    邹文杰(1975- ),男,福建古田人,副教授,博士,研究方向为技术创新与产业发展.

  • 中图分类号: F224.5

China’s Pharmaceutical Manufacturing R&D Efficiency and Its Convergence:Based on the DEA-Malmquist Index Approach

  • 摘要: 运用DEA-Malmquist指数法测算2000—2010年中国医药制造业研发效率,并分析其变化趋势。研究结果表明,中国医药制造业研发效率总体呈增长趋势,其增长的主要动力源于技术效率的改善;医药制造业研发效率区域差异显著,主要原因在于技术进步与技术效率不能协同增长;从变化趋势看,中国东部省份医药制造业研发效率收敛趋势明显,但全国尚未形成医药制造业研发效率的收敛趋势。
    Abstract: This paper uses the DEA-Malmquist Index to measure China's pharmaceutical manufacturing R & D efficiency from 2000 to 2010, and analyze the convergence trend. The results indicate that China's overall pharmaceutical manufacturing R&D efficiency is on an uphill trend, the main driver of growth in R&D efficiency stems from technical efficiency; R&D regional efficiency differs significantly, the main reason being that technological progress and technical efficiency cannot synchronize with growth. Except for the eastern region, central and western regions as well as the national R&D efficiency convergence trend has not yet formed, technology diffusion effect cannot form the main reason for the R&D efficiency unrealized convergence.
  • [1] 郑洁, 杨昌辉, 徐晟. 基于SFA的我国医药制造行业技术创新 效率研究[J]. 合肥工业大学学报:社会科学版, 2008(4):58—63.
    [2] 邹鲜红, 罗承友. 基于DEA模型的我国医药制造业技术创新相对有效性研究[J]. 科技管理研究, 2009(9):252—254.
    [3] 赵丽, 梁静国. 医药制造业新绩效评价指标体系与评价方法研究[J]. 现代管理科学, 2010(5):62—63.
    [4] 吉生保, 周小柯. 中国医药制造业研发效率研究——基于HMB生产率指数的经验证据[J]. 财经论丛, 2010(11):10—15.
    [5] 张永庆, 刘清华, 徐炎. 中国医药制造业研发效率及影响因素[J]. 中国科技论坛, 2011(1):70—74.
    [6] 茅宁莹, 张帅英. 基于DEA方法的我国医药制造业技术创新效率的实证研究[J]. 中国药房, 2012(5):391—394.
    [7] Caves D W, Christensen I R, Deceit W E. The economic theory of index numbers and the measurement of input output and productivity[J]. Economic Erica, 1982, 92:73—86.
    [8] Fare R, Gross Kopf S, Norris M, et al. Productivity growth, technical progress, and efficiency change in industrialized countries[J]. American Economic Review, 1994, 84(1):66—81.
    [9] 王天营, 沈菊华. 样本数据缺失的灰数补救方法[J]. 统计与决策, 2008(22):7—10.
    [10] Barro R, Martin X. The classical approach to convergence analysis[J]. Journal of Political Economy, 1992, 10(1):223—251.
计量
  • 文章访问数:  588
  • HTML全文浏览量:  0
  • PDF下载量:  437
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-01-16
  • 发布日期:  2013-11-24

目录

    /

    返回文章
    返回